tirzepatide for heart health Weight-loss drug may lower failure deaths Lilly's Tirzepatide Reduced Heart Failure

But we do know something is definitely happening to improve heart health

Gallup found that the use of these drugs specifically to lose weight (theyre also used to treat diabetes) has more than doubled from February 2024, when it was 5.8%, to 12.4% currently: More women (15.2%) are taking the drugs than men (9.7%), which correlates with a slightly larger decline in obesity rates among women

Bloating is one of the most common side effects experienced by patients taking GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)

Recently, physicians and researchers recognized that these medications can aid significant weight loss, making them a game-changer for anyone looking to improve their health